PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pediatric Immunology, Hematology and Oncology, Children Hospital of La Timone, AP-HM, Marseille, France.\', \'Unité des Virus Émergents (UVE) Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France.\', \'Department of Pediatric Immunology, Hematology and Oncology, Children Hospital of La Timone, AP-HM, Marseille, France; SMARTc Unit, Centre de Recherche en Cancérologie de Marseille, Inserm U1068, Aix Marseille Univ, Marseille France. Electronic address: Nicolas.andre@ap-hm.fr.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0959-8049(21)00357-910.1016/j.ejca.2021.06.002
?:doi
?:hasPublicationType
?:journal
  • European journal of cancer (Oxford, England : 1990)
is ?:pmid of
?:pmid
?:pmid
  • 34233234
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all